✦ LIBER ✦

Development of a nomogram based on clinical factors for prediction of significant fibrosis in chronic hepatitis C patients

✍ Scribed by E. Sagrini; G. Marano; A. Orlandini; G. Sebastiani; G. Donati; A. Cucchetti; G. Pelosi; A. Gianstefani; C. Ferrari; A. Alberti; L. Bolondi; E. Biganzoli; F. Piscaglia

Book ID: 119229375
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 65 KB
Volume: 41
Category: Article
ISSN: 1590-8658
DOI: 10.1016/j.dld.2008.12.043

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prediction of significant fibrosis in ch

Prediction of significant fibrosis in chronic hepatitis C patients by artificial neural network analysis of clinical factors

✍ F. Piscaglia; A. Cucchetti; A. Orlandini; E. Sagrini; A. Gianstefani; C. Crespi; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Fibroindex, a practical index for predic

Fibroindex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C

✍ Masahiko Koda; Yoshiko Matunaga; Manri Kawakami; Yukihiro Kishimoto; Takeaki Suo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB 👁 2 views

Diagnostic value of multiple biomarker p

Diagnostic value of multiple biomarker panel for prediction of significant fibrosis in chronic hepatitis C

✍ Seung Ha Park; Chang Hoon Kim; Dong Joon Kim; Ki Tae Suk; Jong Ha Park; Jae Youn 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 186 KB

P1018 MARKERS OF COLLAGEN REMODELING DET

P1018 MARKERS OF COLLAGEN REMODELING DETECT CLINICALLY SIGNIFICANT FIBROSIS IN CHRONIC HEPATITIS C PATIENTS

✍ Nielsen, M.J.; Kazankov, K.; Leeming, D.J.; Karsdal, M.A.; Krag, A.; Barrera, F. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 102 KB

Prediction of significant fibrosis in HB

Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model

✍ Min-De Zeng; Lun-Gen Lu; Yi-Min Mao; De-Kai Qiu; Ji-Qiang Li; Mo-Bin Wan; Cheng- 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 2 views

A model was constructed consisting of clinical and serum variables to discriminate between hepatitis B e antigen (HBeAg)-positive chronic hepatitis B (CHB) patients with and without significant fibrosis (stages 2-4 vs. stages 0-1). Consecutive treatment-naive CHB patients who underwent liver biopsy

Clinical-guide risk prediction of hepato

Clinical-guide risk prediction of hepatocellular carcinoma development in chronic hepatitis C patients after interferon-based therapy

✍ Chang, K-C; Wu, Y-Y; Hung, C-H; Lu, S-N; Lee, C-M; Chiu, K-W; Tsai, M-C; Tseng, 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 307 KB